USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
USE OF SULPHATED GLYCOLIPIDS AS PROMOTERS OF NEURITIC GROWTH MYELINATION AND INHIBITING THE PROLIFERATION OF ASTROGLIA AND MICROGLIA USE OF SULPHATED GLYCOLIPIDS AS PROMOTERS OF NEURITIC GROWTH MYELINATION AND INHIBITING THE PROLIFERATION OF ASTROGLIA AND MICROGLIA
USE OF SULPHATED GLYCOLIPIDS AS PROMOTERS OF NEURITIC GROWTH MYELINATION AND INHIBITING THE PROLIFERATION OF ASTROGLIA AND MICROGLIA USE OF SULPHATED GLYCOLIPIDS AS PROMOTERS OF NEURITIC GROWTH MYELINATION AND INHIBITING THE PROLIFERATION OF ASTROGLIA AND MICROGLIA
USE OF THE LIQUID FRACTION OF AN OLIVE MILL SOLID WASTE DIGESTATE IN FERTIRRIGATION TREATMENTS USE OF THE LIQUID FRACTION OF AN OLIVE MILL SOLID WASTE DIGESTATE IN FERTIRRIGATION TREATMENTS
USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME
USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME
USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS ANDOR PROGNOSIS OF HEART FAILURE SYNDROME